FDA Approves First Oral Drug Indicated To Treat Dermatomyositis In Adults
ROIV•FDA approves first oral treatment option for dermatomyositis
- FDA approves first oral drug indicated to treat dermatomyositis in adults.
- Lisraya is the first FDA-approved oral treatment option for patients with dermatomyositis.
